PMID- 12144533 OWN - NLM STAT- MEDLINE DCOM- 20020913 LR - 20191210 IS - 0902-4441 (Print) IS - 0902-4441 (Linking) VI - 68 IP - 5 DP - 2002 May TI - Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the BCR-ABL gene after hematopoietic stem cell transplantation in CML. PG - 272-80 AB - The reverse transcriptase-polymerase chain reaction (RT-PCR) was compared with fluorescence in situ hybridization (FISH) and real-time quantitative RT-PCR (RQ-PCR) for minimal residual disease (MRD) monitoring in 266 post-transplant bone marrow samples from 78 patients with chronic myelogenous leukemia (CML). The sensitivities of FISH to BCR-ABL positive samples determined by first-round (1st) RT-PCR, second-round (2nd) RT-PCR, and RQ-PCR were 64.2%, 25.8%, and 20.7%, respectively. The BCR-ABL/ABL ratio by RQ-PCR had a mean of 0.000 13 in the 1st RT-PCR-negative samples and 1.42 in the 1st RT-PCR-positive samples (P<0.001), and means of 0.000 39 and 0.51 in the 2nd RT-PCR-negative and -positive samples (P< 0.001). The mean ratios of BCR-ABL/ABL by RQ-PCR were significantly different in N/N (1st/2nd RT-PCR) or N/P and P/P (P<0.001), but not in N/N and N/P, which showed that the discriminative power of RQ-PCR is confined to the 1st RT-PCR level. In this respect, monitoring of the 1st RT-PCR might be useful for estimating normalized BCR-ABL levels after transplantation. Nested RT-PCR was of limited use, as RQ-PCR quantified the BCR-ABL transcripts in 60 (91%) of 66 samples determined to be negative by 2nd RT-PCR. FISH was significantly correlated with RQ-PCR in FISH-positive samples (n=24, r=0.79, P=0.001). An increase of FISH preceded that of RQ-PCR in a few cases with molecular relapse. By analyzing a large number of samples post-transplant, we found that RQ-PCR might be the most useful assay for MRD monitoring; however, FISH and RT-PCR were found to be useful complementary tools. FAU - Kim, Yoo-Jin AU - Kim YJ AD - Catholic Hemopoietic Stem Cell Transplantation Center, Catholic University of Korea, #62 Youido-dong, Youngdeungpo-gu, Seoul, Korea (South), 150-713. FAU - Kim, Dong-Wook AU - Kim DW FAU - Lee, Seok AU - Lee S FAU - Kim, Hee-Je AU - Kim HJ FAU - Kim, Yoo-Li AU - Kim YL FAU - Hwang, Ji-Yeon AU - Hwang JY FAU - Oh, Il-Hoan AU - Oh IH FAU - Park, Yoon-Hee AU - Park YH FAU - Lee, You-Kyoung AU - Lee YK FAU - Min, Chang-Ki AU - Min CK FAU - Kim, Tai-Gyu AU - Kim TG FAU - Han, Tae-Hee AU - Han TH FAU - Min, Woo-Sung AU - Min WS FAU - Kim, Chun-Choo AU - Kim CC LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Eur J Haematol JT - European journal of haematology JID - 8703985 RN - 0 (RNA, Messenger) SB - IM MH - Bone Marrow/pathology MH - Feasibility Studies MH - Gene Rearrangement MH - Genes, abl/*genetics MH - Hematopoietic Stem Cell Transplantation MH - Humans MH - In Situ Hybridization, Fluorescence/*standards MH - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*diagnosis/genetics/therapy MH - Methods MH - Neoplasm, Residual/diagnosis/genetics MH - Polymerase Chain Reaction/methods/*standards MH - RNA, Messenger/analysis MH - Reproducibility of Results MH - Reverse Transcriptase Polymerase Chain Reaction/standards EDAT- 2002/07/30 10:00 MHDA- 2002/09/14 10:01 CRDT- 2002/07/30 10:00 PHST- 2002/07/30 10:00 [pubmed] PHST- 2002/09/14 10:01 [medline] PHST- 2002/07/30 10:00 [entrez] AID - 00671 [pii] AID - 10.1034/j.1600-0609.2002.00671.x [doi] PST - ppublish SO - Eur J Haematol. 2002 May;68(5):272-80. doi: 10.1034/j.1600-0609.2002.00671.x.